data_1esx_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1esx _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.8 mtt . . . . . 0 N--CA 1.475 0.811 0 N-CA-C 110.884 -0.043 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -159.56 156.2 27.65 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.516 1.126 . . . . 0.0 109.103 177.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -82.28 69.33 8.99 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.036 0.934 . . . . 0.0 109.018 -178.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -156.72 153.56 24.79 Favored Pre-proline 0 N--CA 1.453 -0.287 0 C-N-CA 125.774 1.629 . . . . 0.0 108.138 -177.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -63.46 -41.35 26.46 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.13 2.553 . . . . 0.0 110.844 177.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -161.34 -48.58 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.827 1.251 . . . . 0.0 109.347 174.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -130.95 162.31 29.99 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 126.784 2.034 . . . . 0.0 108.425 176.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -153.83 -54.44 0.11 Allowed 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.532 0.733 . . . . 0.0 110.039 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 152.85 -79.72 0.19 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 108.379 -1.888 . . . . 0.0 108.379 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -59.46 -61.89 0.2 Allowed 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 123.052 2.501 . . . . 0.0 107.341 174.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -70.73 117.05 11.76 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 173.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -157.31 123.85 4.96 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.353 1.061 . . . . 0.0 108.433 -174.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.451 ' C ' ' H ' ' A' ' 15' ' ' TYR . 7.7 pt-20 -84.72 163.59 45.96 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-O 118.717 -0.659 . . . . 0.0 109.856 174.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -64.8 36.79 0.11 Allowed 'Trans proline' 0 C--N 1.351 0.705 1 C-N-CA 127.581 5.521 . . . . 0.0 117.052 174.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.451 ' H ' ' C ' ' A' ' 13' ' ' GLU . 80.6 m-85 -143.41 -125.5 0.09 Allowed 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 130.303 3.441 . . . . 0.0 103.635 174.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.3 m120 55.95 -126.34 2.05 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 119.503 1.047 . . . . 0.0 110.653 174.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -65.31 -24.81 67.38 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.906 1.682 . . . . 0.0 111.04 -178.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 38.5 t-105 -59.1 -40.57 85.76 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 121.484 0.659 . . . . 0.0 110.212 174.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.1 m -58.75 -45.04 90.6 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.429 -1.26 . . . . 0.0 110.786 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.3 mt -60.01 -49.44 77.65 Favored 'General case' 0 C--O 1.22 -0.454 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 175.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -55.54 -36.81 67.19 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 123.292 0.37 . . . . 0.0 111.624 177.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.7 tt -69.69 -37.66 76.7 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 124.124 0.97 . . . . 0.0 110.657 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.3 tt -72.59 -36.23 68.1 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.119 0.967 . . . . 0.0 110.12 177.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -66.23 -41.27 90.28 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 125.82 1.648 . . . . 0.0 109.468 177.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -64.2 -43.61 94.51 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.153 0.981 . . . . 0.0 109.876 174.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.82 -46.49 84.64 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.832 0.853 . . . . 0.0 109.474 176.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -61.21 -46.22 91.34 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.441 0.697 . . . . 0.0 111.186 177.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -56.3 -48.74 76.07 Favored 'General case' 0 C--N 1.337 0.035 0 C-N-CA 124.182 0.993 . . . . 0.0 110.196 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -61.7 -55.3 31.86 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.164 178.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.97 -41.86 79.13 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.532 1.133 . . . . 0.0 112.118 -174.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.2 p -75.01 -37.0 40.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -176.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.51 -45.14 94.36 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.513 0.725 . . . . 0.0 109.654 174.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.402 ' C ' ' HD2' ' A' ' 35' ' ' PRO . 60.2 t60 -66.88 -15.63 63.77 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 126.816 2.047 . . . . 0.0 113.036 178.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.486 ' N ' ' CD ' ' A' ' 35' ' ' PRO 0.367 11.7 t80 -62.45 -27.96 3.35 Favored Pre-proline 0 CA--C 1.545 0.785 1 N-CA-C 124.464 4.987 . . . . 0.0 124.464 -176.031 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.486 ' CD ' ' N ' ' A' ' 34' ' ' PHE . 93.8 Cg_endo -85.7 -8.07 8.34 Favored 'Trans proline' 0 N--CA 1.442 -1.544 1 C-N-CA 127.587 5.525 . . . . 0.0 110.325 174.499 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.6 tpm_? -100.98 -68.28 0.82 Allowed 'General case' 0 C--N 1.346 0.422 0 C-N-CA 125.495 1.518 . . . . 0.0 109.131 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . 0.255 1.4 tt -2.12 97.7 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 C-N-CA 129.004 2.922 . . . . 0.0 115.114 -174.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -147.37 -79.14 0.15 Allowed 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 109.421 -3.536 . . . . 0.0 109.392 174.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -38.6 -41.92 0.73 Allowed 'General case' 0 C--N 1.342 0.264 0 C-N-CA 127.707 2.403 . . . . 0.0 112.812 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 46.1 t-80 -42.18 -58.6 2.08 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 127.11 2.164 . . . . 0.0 111.67 174.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 74.2 m -92.53 -33.83 14.31 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.392 1.477 . . . . 0.0 111.623 -175.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -56.5 -50.94 70.33 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.855 1.662 . . . . 0.0 110.481 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -59.07 -51.84 56.87 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 124.24 0.924 . . . . 0.0 111.096 178.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -56.02 -44.92 79.19 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.273 1.029 . . . . 0.0 111.218 178.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 60.5 t60 -61.18 -56.16 23.96 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.664 1.186 . . . . 0.0 110.486 -177.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.5 tt -58.85 -47.48 89.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-O 122.012 0.91 . . . . 0.0 110.419 -174.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -51.73 -52.42 48.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 113.741 -1.572 . . . . 0.0 111.183 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -69.68 -73.74 0.15 Allowed 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 125.978 1.711 . . . . 0.0 110.411 -175.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 41.7 p -144.6 103.29 3.92 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.596 1.558 . . . . 0.0 109.149 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -80.7 -53.6 6.38 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 122.508 0.323 . . . . 0.0 111.755 -177.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -91.06 -27.59 18.19 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 177.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.3 t70 56.69 24.46 8.98 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 127.007 2.123 . . . . 0.0 112.524 -176.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.7 m -149.62 83.19 1.41 Allowed 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -177.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 20.2 p90 40.21 40.41 0.8 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.296 1.839 . . . . 0.0 113.185 -174.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.4 m -145.84 -57.15 0.31 Allowed 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 128.93 2.892 . . . . 0.0 106.029 -175.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -89.45 -31.71 11.26 Favored Glycine 0 C--O 1.222 -0.596 0 N-CA-C 107.998 -2.041 . . . . 0.0 107.998 173.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 74.3 t -60.08 -37.65 73.74 Favored 'Isoleucine or valine' 0 C--N 1.34 0.18 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 174.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -64.65 -39.08 93.07 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 124.904 1.282 . . . . 0.0 110.913 174.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.22 -44.95 93.83 Favored 'General case' 0 CA--C 1.528 0.129 0 O-C-N 123.193 0.308 . . . . 0.0 110.627 175.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 54.3 tp -60.87 -44.16 97.43 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.837 0.855 . . . . 0.0 110.914 177.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 9.0 mm -60.94 -35.26 63.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 123.554 0.742 . . . . 0.0 110.359 174.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.46 -40.17 96.41 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.772 0.429 . . . . 0.0 111.146 176.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 98.9 mt -61.54 -41.74 91.32 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 175.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.09 -41.14 97.9 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 122.565 0.346 . . . . 0.0 110.903 175.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -64.77 -43.5 93.05 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 124.571 1.148 . . . . 0.0 111.679 -177.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.5 tm0? -54.81 -48.11 73.21 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 125.23 1.412 . . . . 0.0 109.373 174.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.5 tp -61.11 -52.7 63.8 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.632 -178.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -55.69 -47.55 76.61 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 126.25 1.82 . . . . 0.0 110.445 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -54.82 -45.47 74.41 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.029 0.931 . . . . 0.0 110.817 176.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 18.7 mm -61.52 -47.44 93.37 Favored 'Isoleucine or valine' 0 C--N 1.34 0.153 0 CA-C-N 118.123 0.42 . . . . 0.0 110.854 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -61.03 -41.64 96.95 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 122.998 0.519 . . . . 0.0 111.109 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -58.95 -48.48 81.37 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.012 1.325 . . . . 0.0 110.348 176.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.8 ttp85 -57.36 -47.7 80.94 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.795 0.838 . . . . 0.0 110.873 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 90.6 mt -61.36 -45.37 98.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 123.964 0.905 . . . . 0.0 110.419 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.1 -47.53 86.82 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 123.801 0.715 . . . . 0.0 111.596 175.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 47.8 t -66.1 -41.78 90.16 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.091 0.956 . . . . 0.0 111.05 -178.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 51.2 ttt85 -53.8 -45.7 70.85 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 174.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -91.11 54.09 2.52 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.611 1.164 . . . . 0.0 110.483 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 33.7 t -161.12 -58.05 0.05 Allowed 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.584 1.154 . . . . 0.0 109.34 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 26.5 mmt85 -66.8 -18.6 65.46 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -177.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 33.7 pt -73.86 -7.36 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 123.778 0.831 . . . . 0.0 112.11 174.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.45 58.78 0.26 Allowed Glycine 0 C--N 1.34 0.8 0 N-CA-C 109.304 -1.519 . . . . 0.0 109.304 -174.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 72.0 mt -52.86 -46.81 52.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 124.59 1.156 . . . . 0.0 110.315 178.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.9 mt -106.82 42.19 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 126.263 1.825 . . . . 0.0 108.112 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . 0.292 0.7 OUTLIER -76.48 69.69 2.96 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-O 123.158 1.456 . . . . 0.0 107.668 174.651 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 57.44 51.22 10.1 Favored 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 128.493 2.717 . . . . 0.0 106.256 -173.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . 0.466 2.5 ptp180 44.93 52.98 7.89 Favored 'General case' 0 N--CA 1.434 -1.253 2 C-N-CA 134.085 4.954 . . . . 0.0 110.669 -173.497 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 47.7 ttt85 -45.79 -52.24 11.47 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 128.196 2.598 . . . . 0.0 112.236 177.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.6 p -100.95 -44.5 5.72 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.56 1.144 . . . . 0.0 111.044 -174.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 66.6 mtt-85 -79.52 71.66 6.13 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.813 0.845 . . . . 0.0 109.493 176.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -80.36 57.9 2.95 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.809 1.244 . . . . 0.0 111.195 -176.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -79.16 -99.43 0.25 Allowed Glycine 0 CA--C 1.527 0.835 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 174.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.18 68.25 5.1 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 174.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 50.1 m -55.43 86.97 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 127.34 2.256 . . . . 0.0 113.396 -174.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -140.94 -63.96 0.46 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 126.141 1.776 . . . . 0.0 107.087 174.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 31.5 t . . . . . 0 C--O 1.252 1.217 0 C-N-CA 125.828 1.651 . . . . 0.0 107.779 174.776 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.8 mtt . . . . . 0 N--CA 1.475 0.811 0 N-CA-C 110.884 -0.043 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -159.56 156.2 27.65 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.516 1.126 . . . . 0.0 109.103 177.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -82.28 69.33 8.99 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.036 0.934 . . . . 0.0 109.018 -178.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -156.72 153.56 24.79 Favored Pre-proline 0 N--CA 1.453 -0.287 0 C-N-CA 125.774 1.629 . . . . 0.0 108.138 -177.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -63.46 -41.35 26.46 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.13 2.553 . . . . 0.0 110.844 177.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -161.34 -48.58 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.827 1.251 . . . . 0.0 109.347 174.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -130.95 162.31 29.99 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 126.784 2.034 . . . . 0.0 108.425 176.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -153.83 -54.44 0.11 Allowed 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.532 0.733 . . . . 0.0 110.039 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 152.85 -79.72 0.19 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 108.379 -1.888 . . . . 0.0 108.379 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -59.46 -61.89 0.2 Allowed 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 123.052 2.501 . . . . 0.0 107.341 174.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -70.73 117.05 11.76 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 173.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -157.31 123.85 4.96 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.353 1.061 . . . . 0.0 108.433 -174.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.408 ' C ' ' H ' ' A' ' 15' ' ' TYR . 7.7 pt-20 -84.72 163.59 45.96 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-O 118.717 -0.659 . . . . 0.0 109.856 174.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -64.8 36.79 0.11 Allowed 'Trans proline' 0 C--N 1.351 0.705 1 C-N-CA 127.581 5.521 . . . . 0.0 117.052 174.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.408 ' H ' ' C ' ' A' ' 13' ' ' GLU . 80.6 m-85 -143.41 -125.5 0.09 Allowed 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 130.303 3.441 . . . . 0.0 103.635 174.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.3 m120 55.95 -126.34 2.05 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 119.503 1.047 . . . . 0.0 110.653 174.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -65.31 -24.81 67.38 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.906 1.682 . . . . 0.0 111.04 -178.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 38.5 t-105 -59.1 -40.57 85.76 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 121.484 0.659 . . . . 0.0 110.212 174.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.1 m -58.75 -45.04 90.6 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.429 -1.26 . . . . 0.0 110.786 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.3 mt -60.01 -49.44 77.65 Favored 'General case' 0 C--O 1.22 -0.454 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 175.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -55.54 -36.81 67.19 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 123.292 0.37 . . . . 0.0 111.624 177.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.7 tt -69.69 -37.66 76.7 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 124.124 0.97 . . . . 0.0 110.657 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.3 tt -72.59 -36.23 68.1 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.119 0.967 . . . . 0.0 110.12 177.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -66.23 -41.27 90.28 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 125.82 1.648 . . . . 0.0 109.468 177.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -64.2 -43.61 94.51 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.153 0.981 . . . . 0.0 109.876 174.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.82 -46.49 84.64 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.832 0.853 . . . . 0.0 109.474 176.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -61.21 -46.22 91.34 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.441 0.697 . . . . 0.0 111.186 177.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -56.3 -48.74 76.07 Favored 'General case' 0 C--N 1.337 0.035 0 C-N-CA 124.182 0.993 . . . . 0.0 110.196 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -61.7 -55.3 31.86 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.164 178.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.97 -41.86 79.13 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.532 1.133 . . . . 0.0 112.118 -174.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.2 p -75.01 -37.0 40.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -176.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.51 -45.14 94.36 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.513 0.725 . . . . 0.0 109.654 174.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 60.2 t60 -66.88 -15.63 63.77 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 126.816 2.047 . . . . 0.0 113.036 178.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.486 ' N ' ' CD ' ' A' ' 35' ' ' PRO 0.367 11.7 t80 -62.45 -27.96 3.35 Favored Pre-proline 0 CA--C 1.545 0.785 1 N-CA-C 124.464 4.987 . . . . 0.0 124.464 -176.031 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.486 ' CD ' ' N ' ' A' ' 34' ' ' PHE . 93.8 Cg_endo -85.7 -8.07 8.34 Favored 'Trans proline' 0 N--CA 1.442 -1.544 1 C-N-CA 127.587 5.525 . . . . 0.0 110.325 174.499 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.6 tpm_? -100.98 -68.28 0.82 Allowed 'General case' 0 C--N 1.346 0.422 0 C-N-CA 125.495 1.518 . . . . 0.0 109.131 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . 0.255 1.4 tt -2.12 97.7 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 C-N-CA 129.004 2.922 . . . . 0.0 115.114 -174.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -147.37 -79.14 0.15 Allowed 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 109.421 -3.536 . . . . 0.0 109.392 174.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -38.6 -41.92 0.73 Allowed 'General case' 0 C--N 1.342 0.264 0 C-N-CA 127.707 2.403 . . . . 0.0 112.812 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 46.1 t-80 -42.18 -58.6 2.08 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 127.11 2.164 . . . . 0.0 111.67 174.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 74.2 m -92.53 -33.83 14.31 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.392 1.477 . . . . 0.0 111.623 -175.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -56.5 -50.94 70.33 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.855 1.662 . . . . 0.0 110.481 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -59.07 -51.84 56.87 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 124.24 0.924 . . . . 0.0 111.096 178.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -56.02 -44.92 79.19 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.273 1.029 . . . . 0.0 111.218 178.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 60.5 t60 -61.18 -56.16 23.96 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.664 1.186 . . . . 0.0 110.486 -177.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.5 tt -58.85 -47.48 89.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-O 122.012 0.91 . . . . 0.0 110.419 -174.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -51.73 -52.42 48.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 113.741 -1.572 . . . . 0.0 111.183 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -69.68 -73.74 0.15 Allowed 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 125.978 1.711 . . . . 0.0 110.411 -175.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 41.7 p -144.6 103.29 3.92 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.596 1.558 . . . . 0.0 109.149 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -80.7 -53.6 6.38 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 122.508 0.323 . . . . 0.0 111.755 -177.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -91.06 -27.59 18.19 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 177.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.435 ' H ' ' HA3' ' A' ' 56' ' ' GLY . 4.3 t70 56.69 24.46 8.98 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 127.007 2.123 . . . . 0.0 112.524 -176.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.7 m -149.62 83.19 1.41 Allowed 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -177.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 20.2 p90 40.21 40.41 0.8 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.296 1.839 . . . . 0.0 113.185 -174.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.4 m -145.84 -57.15 0.31 Allowed 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 128.93 2.892 . . . . 0.0 106.029 -175.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.435 ' HA3' ' H ' ' A' ' 52' ' ' ASP . . . -89.45 -31.71 11.26 Favored Glycine 0 C--O 1.222 -0.596 0 N-CA-C 107.998 -2.041 . . . . 0.0 107.998 173.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 74.3 t -60.08 -37.65 73.74 Favored 'Isoleucine or valine' 0 C--N 1.34 0.18 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 174.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -64.65 -39.08 93.07 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 124.904 1.282 . . . . 0.0 110.913 174.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.22 -44.95 93.83 Favored 'General case' 0 CA--C 1.528 0.129 0 O-C-N 123.193 0.308 . . . . 0.0 110.627 175.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 54.3 tp -60.87 -44.16 97.43 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.837 0.855 . . . . 0.0 110.914 177.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 9.0 mm -60.94 -35.26 63.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 123.554 0.742 . . . . 0.0 110.359 174.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.46 -40.17 96.41 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.772 0.429 . . . . 0.0 111.146 176.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 98.9 mt -61.54 -41.74 91.32 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 175.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.09 -41.14 97.9 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 122.565 0.346 . . . . 0.0 110.903 175.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -64.77 -43.5 93.05 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 124.571 1.148 . . . . 0.0 111.679 -177.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.5 tm0? -54.81 -48.11 73.21 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 125.23 1.412 . . . . 0.0 109.373 174.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.5 tp -61.11 -52.7 63.8 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.632 -178.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -55.69 -47.55 76.61 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 126.25 1.82 . . . . 0.0 110.445 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -54.82 -45.47 74.41 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.029 0.931 . . . . 0.0 110.817 176.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 18.7 mm -61.52 -47.44 93.37 Favored 'Isoleucine or valine' 0 C--N 1.34 0.153 0 CA-C-N 118.123 0.42 . . . . 0.0 110.854 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -61.03 -41.64 96.95 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 122.998 0.519 . . . . 0.0 111.109 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -58.95 -48.48 81.37 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.012 1.325 . . . . 0.0 110.348 176.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.8 ttp85 -57.36 -47.7 80.94 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.795 0.838 . . . . 0.0 110.873 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 90.6 mt -61.36 -45.37 98.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 123.964 0.905 . . . . 0.0 110.419 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.1 -47.53 86.82 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 123.801 0.715 . . . . 0.0 111.596 175.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 47.8 t -66.1 -41.78 90.16 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.091 0.956 . . . . 0.0 111.05 -178.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 51.2 ttt85 -53.8 -45.7 70.85 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 174.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -91.11 54.09 2.52 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.611 1.164 . . . . 0.0 110.483 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 33.7 t -161.12 -58.05 0.05 Allowed 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.584 1.154 . . . . 0.0 109.34 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 26.5 mmt85 -66.8 -18.6 65.46 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -177.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 33.7 pt -73.86 -7.36 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 123.778 0.831 . . . . 0.0 112.11 174.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.45 58.78 0.26 Allowed Glycine 0 C--N 1.34 0.8 0 N-CA-C 109.304 -1.519 . . . . 0.0 109.304 -174.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 72.0 mt -52.86 -46.81 52.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 124.59 1.156 . . . . 0.0 110.315 178.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.9 mt -106.82 42.19 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 126.263 1.825 . . . . 0.0 108.112 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . 0.292 0.7 OUTLIER -76.48 69.69 2.96 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-O 123.158 1.456 . . . . 0.0 107.668 174.651 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 57.44 51.22 10.1 Favored 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 128.493 2.717 . . . . 0.0 106.256 -173.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . 0.466 2.5 ptp180 44.93 52.98 7.89 Favored 'General case' 0 N--CA 1.434 -1.253 2 C-N-CA 134.085 4.954 . . . . 0.0 110.669 -173.497 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 47.7 ttt85 -45.79 -52.24 11.47 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 128.196 2.598 . . . . 0.0 112.236 177.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.6 p -100.95 -44.5 5.72 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.56 1.144 . . . . 0.0 111.044 -174.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 66.6 mtt-85 -79.52 71.66 6.13 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.813 0.845 . . . . 0.0 109.493 176.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -80.36 57.9 2.95 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.809 1.244 . . . . 0.0 111.195 -176.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -79.16 -99.43 0.25 Allowed Glycine 0 CA--C 1.527 0.835 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 174.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.18 68.25 5.1 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 174.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 50.1 m -55.43 86.97 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 127.34 2.256 . . . . 0.0 113.396 -174.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -140.94 -63.96 0.46 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 126.141 1.776 . . . . 0.0 107.087 174.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 31.5 t . . . . . 0 C--O 1.252 1.217 0 C-N-CA 125.828 1.651 . . . . 0.0 107.779 174.776 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.8 mtt . . . . . 0 N--CA 1.475 0.811 0 N-CA-C 110.884 -0.043 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -159.56 156.2 27.65 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.516 1.126 . . . . 0.0 109.103 177.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -82.28 69.33 8.99 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.036 0.934 . . . . 0.0 109.018 -178.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -156.72 153.56 24.79 Favored Pre-proline 0 N--CA 1.453 -0.287 0 C-N-CA 125.774 1.629 . . . . 0.0 108.138 -177.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -63.46 -41.35 26.46 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.13 2.553 . . . . 0.0 110.844 177.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -161.34 -48.58 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.827 1.251 . . . . 0.0 109.347 174.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -130.95 162.31 29.99 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 126.784 2.034 . . . . 0.0 108.425 176.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -153.83 -54.44 0.11 Allowed 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.532 0.733 . . . . 0.0 110.039 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 152.85 -79.72 0.19 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 108.379 -1.888 . . . . 0.0 108.379 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -59.46 -61.89 0.2 Allowed 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 123.052 2.501 . . . . 0.0 107.341 174.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -70.73 117.05 11.76 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 173.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -157.31 123.85 4.96 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.353 1.061 . . . . 0.0 108.433 -174.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.408 ' C ' ' H ' ' A' ' 15' ' ' TYR . 7.7 pt-20 -84.72 163.59 45.96 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-O 118.717 -0.659 . . . . 0.0 109.856 174.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -64.8 36.79 0.11 Allowed 'Trans proline' 0 C--N 1.351 0.705 1 C-N-CA 127.581 5.521 . . . . 0.0 117.052 174.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.408 ' H ' ' C ' ' A' ' 13' ' ' GLU . 80.6 m-85 -143.41 -125.5 0.09 Allowed 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 130.303 3.441 . . . . 0.0 103.635 174.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.3 m120 55.95 -126.34 2.05 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 119.503 1.047 . . . . 0.0 110.653 174.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -65.31 -24.81 67.38 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.906 1.682 . . . . 0.0 111.04 -178.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' TRP . . . . . . . . . . . . . 38.5 t-105 -59.1 -40.57 85.76 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-O 121.484 0.659 . . . . 0.0 110.212 174.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.1 m -58.75 -45.04 90.6 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.429 -1.26 . . . . 0.0 110.786 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.3 mt -60.01 -49.44 77.65 Favored 'General case' 0 C--O 1.22 -0.454 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 175.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -55.54 -36.81 67.19 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 123.292 0.37 . . . . 0.0 111.624 177.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.7 tt -69.69 -37.66 76.7 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 124.124 0.97 . . . . 0.0 110.657 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.3 tt -72.59 -36.23 68.1 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 124.119 0.967 . . . . 0.0 110.12 177.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -66.23 -41.27 90.28 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 125.82 1.648 . . . . 0.0 109.468 177.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -64.2 -43.61 94.51 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.153 0.981 . . . . 0.0 109.876 174.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.82 -46.49 84.64 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 123.832 0.853 . . . . 0.0 109.474 176.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -61.21 -46.22 91.34 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.441 0.697 . . . . 0.0 111.186 177.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -56.3 -48.74 76.07 Favored 'General case' 0 C--N 1.337 0.035 0 C-N-CA 124.182 0.993 . . . . 0.0 110.196 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -61.7 -55.3 31.86 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.164 178.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -56.97 -41.86 79.13 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.532 1.133 . . . . 0.0 112.118 -174.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.2 p -75.01 -37.0 40.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -176.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.51 -45.14 94.36 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.513 0.725 . . . . 0.0 109.654 174.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 60.2 t60 -66.88 -15.63 63.77 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 126.816 2.047 . . . . 0.0 113.036 178.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.486 ' N ' ' CD ' ' A' ' 35' ' ' PRO 0.367 11.7 t80 -62.45 -27.96 3.35 Favored Pre-proline 0 CA--C 1.545 0.785 1 N-CA-C 124.464 4.987 . . . . 0.0 124.464 -176.031 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.486 ' CD ' ' N ' ' A' ' 34' ' ' PHE . 93.8 Cg_endo -85.7 -8.07 8.34 Favored 'Trans proline' 0 N--CA 1.442 -1.544 1 C-N-CA 127.587 5.525 . . . . 0.0 110.325 174.499 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.6 tpm_? -100.98 -68.28 0.82 Allowed 'General case' 0 C--N 1.346 0.422 0 C-N-CA 125.495 1.518 . . . . 0.0 109.131 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . 0.255 1.4 tt -2.12 97.7 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 C-N-CA 129.004 2.922 . . . . 0.0 115.114 -174.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -147.37 -79.14 0.15 Allowed 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 109.421 -3.536 . . . . 0.0 109.392 174.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -38.6 -41.92 0.73 Allowed 'General case' 0 C--N 1.342 0.264 0 C-N-CA 127.707 2.403 . . . . 0.0 112.812 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 46.1 t-80 -42.18 -58.6 2.08 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 127.11 2.164 . . . . 0.0 111.67 174.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 74.2 m -92.53 -33.83 14.31 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.392 1.477 . . . . 0.0 111.623 -175.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -56.5 -50.94 70.33 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.855 1.662 . . . . 0.0 110.481 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -59.07 -51.84 56.87 Favored Glycine 0 CA--C 1.525 0.694 0 C-N-CA 124.24 0.924 . . . . 0.0 111.096 178.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -56.02 -44.92 79.19 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.273 1.029 . . . . 0.0 111.218 178.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 60.5 t60 -61.18 -56.16 23.96 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.664 1.186 . . . . 0.0 110.486 -177.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.5 tt -58.85 -47.48 89.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-O 122.012 0.91 . . . . 0.0 110.419 -174.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -51.73 -52.42 48.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 113.741 -1.572 . . . . 0.0 111.183 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -69.68 -73.74 0.15 Allowed 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 125.978 1.711 . . . . 0.0 110.411 -175.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 41.7 p -144.6 103.29 3.92 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.596 1.558 . . . . 0.0 109.149 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -80.7 -53.6 6.38 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 122.508 0.323 . . . . 0.0 111.755 -177.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -91.06 -27.59 18.19 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 177.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.435 ' H ' ' HA3' ' A' ' 56' ' ' GLY . 4.3 t70 56.69 24.46 8.98 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 127.007 2.123 . . . . 0.0 112.524 -176.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 88.7 m -149.62 83.19 1.41 Allowed 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -177.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 20.2 p90 40.21 40.41 0.8 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.296 1.839 . . . . 0.0 113.185 -174.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.4 m -145.84 -57.15 0.31 Allowed 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 128.93 2.892 . . . . 0.0 106.029 -175.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.435 ' HA3' ' H ' ' A' ' 52' ' ' ASP . . . -89.45 -31.71 11.26 Favored Glycine 0 C--O 1.222 -0.596 0 N-CA-C 107.998 -2.041 . . . . 0.0 107.998 173.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 74.3 t -60.08 -37.65 73.74 Favored 'Isoleucine or valine' 0 C--N 1.34 0.18 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 174.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -64.65 -39.08 93.07 Favored 'General case' 0 N--CA 1.429 -1.488 0 C-N-CA 124.904 1.282 . . . . 0.0 110.913 174.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.22 -44.95 93.83 Favored 'General case' 0 CA--C 1.528 0.129 0 O-C-N 123.193 0.308 . . . . 0.0 110.627 175.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 54.3 tp -60.87 -44.16 97.43 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.837 0.855 . . . . 0.0 110.914 177.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 9.0 mm -60.94 -35.26 63.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 123.554 0.742 . . . . 0.0 110.359 174.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.46 -40.17 96.41 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.772 0.429 . . . . 0.0 111.146 176.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 98.9 mt -61.54 -41.74 91.32 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 175.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.09 -41.14 97.9 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 122.565 0.346 . . . . 0.0 110.903 175.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -64.77 -43.5 93.05 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 124.571 1.148 . . . . 0.0 111.679 -177.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.5 tm0? -54.81 -48.11 73.21 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 125.23 1.412 . . . . 0.0 109.373 174.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.5 tp -61.11 -52.7 63.8 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.632 -178.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -55.69 -47.55 76.61 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 126.25 1.82 . . . . 0.0 110.445 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -54.82 -45.47 74.41 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.029 0.931 . . . . 0.0 110.817 176.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 18.7 mm -61.52 -47.44 93.37 Favored 'Isoleucine or valine' 0 C--N 1.34 0.153 0 CA-C-N 118.123 0.42 . . . . 0.0 110.854 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -61.03 -41.64 96.95 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 122.998 0.519 . . . . 0.0 111.109 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -58.95 -48.48 81.37 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 125.012 1.325 . . . . 0.0 110.348 176.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 9.8 ttp85 -57.36 -47.7 80.94 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.795 0.838 . . . . 0.0 110.873 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 90.6 mt -61.36 -45.37 98.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 123.964 0.905 . . . . 0.0 110.419 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.1 -47.53 86.82 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 123.801 0.715 . . . . 0.0 111.596 175.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 47.8 t -66.1 -41.78 90.16 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 124.091 0.956 . . . . 0.0 111.05 -178.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 51.2 ttt85 -53.8 -45.7 70.85 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 174.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 17.3 m-70 -91.11 54.09 2.52 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.611 1.164 . . . . 0.0 110.483 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 33.7 t -161.12 -58.05 0.05 Allowed 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.584 1.154 . . . . 0.0 109.34 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 26.5 mmt85 -66.8 -18.6 65.46 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -177.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 33.7 pt -73.86 -7.36 9.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 123.778 0.831 . . . . 0.0 112.11 174.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.45 58.78 0.26 Allowed Glycine 0 C--N 1.34 0.8 0 N-CA-C 109.304 -1.519 . . . . 0.0 109.304 -174.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 72.0 mt -52.86 -46.81 52.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 124.59 1.156 . . . . 0.0 110.315 178.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.9 mt -106.82 42.19 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 126.263 1.825 . . . . 0.0 108.112 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . 0.292 0.7 OUTLIER -76.48 69.69 2.96 Favored 'General case' 0 C--N 1.345 0.402 0 CA-C-O 123.158 1.456 . . . . 0.0 107.668 174.651 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 57.44 51.22 10.1 Favored 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 128.493 2.717 . . . . 0.0 106.256 -173.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . 0.466 2.5 ptp180 44.93 52.98 7.89 Favored 'General case' 0 N--CA 1.434 -1.253 2 C-N-CA 134.085 4.954 . . . . 0.0 110.669 -173.497 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 47.7 ttt85 -45.79 -52.24 11.47 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 128.196 2.598 . . . . 0.0 112.236 177.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.6 p -100.95 -44.5 5.72 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.56 1.144 . . . . 0.0 111.044 -174.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 66.6 mtt-85 -79.52 71.66 6.13 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.813 0.845 . . . . 0.0 109.493 176.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -80.36 57.9 2.95 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.809 1.244 . . . . 0.0 111.195 -176.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -79.16 -99.43 0.25 Allowed Glycine 0 CA--C 1.527 0.835 0 N-CA-C 109.045 -1.622 . . . . 0.0 109.045 174.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.18 68.25 5.1 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 174.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 50.1 m -55.43 86.97 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 127.34 2.256 . . . . 0.0 113.396 -174.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -140.94 -63.96 0.46 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 126.141 1.776 . . . . 0.0 107.087 174.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 31.5 t . . . . . 0 C--O 1.252 1.217 0 C-N-CA 125.828 1.651 . . . . 0.0 107.779 174.776 . . . . . . . . 0 0 . 1 stop_ save_